GILDbenzinga

Cantor Fitzgerald Assumes Gilead Sciences at Overweight, Announces Price Target of $125

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on April 22, 2025 by benzinga